The Diagnostic Journey of Fahr’s Syndrome: A Case Report of Misdiagnosed Multisystem and Neuropsychiatric Symptoms Due to Hypocalcemia Secondary to Hypoparathyroidism
Downloads
Published
DOI:
https://doi.org/10.54169/ijocp.v4i02.146Keywords:
Depression, Anxiety, Basal ganglia calcification, Hypoparathyroidism, Fahr disease.Dimensions Badge
Issue
Section
License
Copyright (c) 2024 Govind Madhaw, Suparna Kumar

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Simultaneous psychiatric and neurological manifestations with multisystem involvement often create diagnostic dilemmas and increase the expenditure of undiagnosed cases. It is crucial to rule out reversible medical pathologies before labeling them as primary psychiatric disorders. We present the case of a 50-year-old female complaining of episodic breathlessness with a provisional diagnosis of asthma by a pulmonologist and later on depressive cognition panic attacks pointed towards the diagnosis of moderate depressive episode with somatic symptoms and panic disorder by a psychiatrist. Despite treatment, there was no improvement and new onset focal seizures leading to generalized tonic-clonic seizures evolved. Neuroimaging revealed bilateral diffuse hyperdense parenchymal calcification and metabolic profile showed hypocalcemia secondary to hypoparathyroidism, confirming the diagnosis of Fahr’s syndrome. She was prescribed antiepileptics to control seizures and supplemented with high doses of calcium, vitamin D and magnesium. She became asymptomatic within a month. Hence, our case highlights the importance of neuroimaging and metabolic profiles in uncovering hidden aetiologies and formulating individualized treatment strategies.Abstract
How to Cite
Downloads
Similar Articles
- Tapas Kumar Aich, Amil H Khan, Prabhat Kumar Agrawal, Mental Health Issues in Covid and Post Covid-19 Scenario: The Way Forward , Indian Journal of Clinical Psychiatry: Vol. 1 No. 1 (2021): Indian Journal of Clinical Psychiatry
- Shobit Garg, E. Mohandas, Cannabidiol (CBD) in Psychiatry: Therapeutic Potential and Challenges in the Indian Context , Indian Journal of Clinical Psychiatry: Vol. 5 No. 02 (2025): Indian Journal of Clinical Psychiatry
- Maryam Farzan, Hamid Ebrahimi, Maryam Pourali, Existential Concerns and Interventions in Patients with Cancer: Insights from Yalom’s Framework , Indian Journal of Clinical Psychiatry: Vol. 4 No. 02 (2024): Indian Journal of Clinical Psychiatry
- Ishwari Jadhav, Kunal Doshi, Case Report: Thalamic Stroke Patient with Neuropsychiatric Symptoms , Indian Journal of Clinical Psychiatry: Vol. 4 No. 01 (2024): Indian Journal of Clinical Psychiatry
- Chitrakshee Singh, Vipul Singh, Dharamveer Choudhary, Priyanka Kumari, Violence in Psychiatry - An Over-emphasised Subject , Indian Journal of Clinical Psychiatry: Vol. 2 No. 01 (2022): Indian Journal of Clinical Psychiatry
- Mohit kumar Shahi mohit, Ashwin J.V, Astha Singh, Dhat Syndrome in Geriatric Population: Cultural Beliefs and Implications , Indian Journal of Clinical Psychiatry: Vol. 3 No. 02 (2023): Indian Journal of Clinical Psychiatry
- Sujita K. Kar, Babli Kumari, Amit Singh, Neuromodulation in bipolar disorder: Diversity of evidences & Practice recommendations , Indian Journal of Clinical Psychiatry: Vol. 2 No. 02 (2022): Indian Journal of Clinical Psychiatry
- Dr. Samia Ansari, Mona Srivastava, Bipolar Disorder in the Life Span of Females: Treatment Implications , Indian Journal of Clinical Psychiatry: Vol. 2 No. 02 (2022): Indian Journal of Clinical Psychiatry
You may also start an advanced similarity search for this article.



